Vast Therapeutics, Inc.

Morrisville, NC Doing business as Vast Therapeutics Inc.

UEI
CYDMYQAP1ZW7
CAGE
81V62
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
615 Davis Dr #800, Morrisville, NC 27560, USA
Website
vasttherapeutics.com
Founded
2017
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Vast Therapeutics, Inc.'s 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Nebulized ALX1 as a treatment for difficult non-tuberculous mycobacterial lung infections - summary non-tuberculosis… Grant · R44AI186617 National Institute of Allergy and Infectious Diseases $1,950,129
Nebulized ALX1 as a treatment for pseudomonas aeruginosa infections in bronchiectasis patients - summary… Grant · R44AI184225 National Institute of Allergy and Infectious Diseases $3,988,594

Quick answers

What is Vast Therapeutics, Inc.'s UEI?

Vast Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is CYDMYQAP1ZW7.

What is Vast Therapeutics, Inc.'s CAGE code?

Vast Therapeutics, Inc.'s CAGE code is 81V62.

Where is Vast Therapeutics, Inc. located?

Vast Therapeutics, Inc.'s physical address in SAM.gov is 615 Davis Dr #800, Morrisville, NC 27560, USA.

Is Vast Therapeutics, Inc. registered in SAM.gov?

Yes. Vast Therapeutics, Inc.'s SAM.gov registration is active through June 5, 2027.

What is Vast Therapeutics, Inc.'s most recent federal award?

Vast Therapeutics, Inc.'s most recent federal grant award is Nebulized ALX1 as a treatment for difficult non-tuberculous mycobacterial lung infections - summary non-tuberculosis… (R44AI186617), from National Institute of Allergy and Infectious Diseases, on September 11, 2025.

On GovTribe

See Vast Therapeutics, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login